TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 2 | 8 | -13 | -18 | -17 | -19 | -9 |
| P | %wins | 100 | 100 | 50 | 0 | 50 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/15 17:01 | 11/3/15 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Holmes Scott A | NY | O | CFO | P.m | 27 | 5.33 | 14 | 5 | 9 | 60 | D | -51 | -67 | -45 | -21 | 35 | 35 | 31 | 20 | 3 | 2 | 3 | -28 | 6 | -17 |
8/24/15 18:06 | 8/21/15 | KERX | Keryx Biopharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Holmes Scott A | NY | O | CFO | P | 29 | 5.72 | 12 | 5 | 10 | 55 | D | -34 | -63 | -53 | -44 | -41 | -23 | -11 | -7 | 0 | 14 | -29 | -7 | -40 | -20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |